# The Implication of Plasma ctDNA Methylation Haplotypes in Detecting Colorectal Cancer and Adenomas

> **NCT03737591** · — · COMPLETED · sponsor: **Fudan University** · enrollment: 1138 (actual)

## Conditions studied

- Colorectal Cancer
- Adenoma

## Interventions

- **DIAGNOSTIC_TEST:** Next-generation sequencing (NGS)

## Key facts

- **NCT ID:** NCT03737591
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 1138 (ACTUAL)
- **Last updated:** 2022-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03737591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03737591, "The Implication of Plasma ctDNA Methylation Haplotypes in Detecting Colorectal Cancer and Adenomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03737591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*